The massive PBM’s announcement comes as the drug middlemen attempt to lessen regulatory scrutiny. The company also said it will move to a cost-plus reimbursement model for in-network pharmacies.

Cigna announced Monday morning that what it's calling a "new era" for its PBM unit is built on three core elements: transparency, a better patient experience and greater support for community ...

Pharmacy benefit manager Express Scripts is continuing to push back against the class-action lawsuit filed on behalf of ...

Newly published court documents show that the PBM Express Scripts has filed a motion to dismiss its ongoing legal battle with ...

Two dozen Democrat and Republican lawmakers have raised issues about Express Scripts, the company that oversees the U.S. military's pharmacy program, charging that the benefits manager engages in ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. [<a href="http://storify.com/dnickbiz/walgreens-enlists-social-media-in-fight-with-expre ...

Philadelphia has sued major pharmacy benefit managers, alleging their marketing and distribution of opioids contributed to ...

Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen ...

Turing Pharmaceuticals incited outrage over the high cost of specialty drugs after raising the price of Daraprim by 5,000 percent overnight in September. Now, Express Scripts, the largest pharmacy ...

The nation’s second-largest pharmacy benefit manager, Express Scripts, is leaning into Mark Cuban Cost Plus Drugs’ business plan by selling drugs priced by their acquisition cost, pharmacy dispensing ...

The specialty grocer, which spends millions each year on insulin for employees, accused the companies of profiting from ...

Express Scripts, the pharmacy benefits management business of the Cigna Group's Evernorth, will add three additional biosimilars to its National Preferred Formulary that it said will compete with ...